By Michele Maatouk
Date: Tuesday 31 Mar 2026
(Sharecast News) - Shares in Apellis Pharmaceuticals rocketed on Tuesday after it agreed to be bought by Biogen in a $5.6bn deal.
By Abigail Townsend
Date: Wednesday 20 Oct 2021
(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.
By Abigail Townsend
Date: Tuesday 08 Jun 2021
(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.
| Currency | US Dollars |
| Share Price | $ 177.35 |
| Change Today | $ 1.33 |
| % Change | 0.76 % |
| 52 Week High | $201.18 |
| 52 Week Low | $118.84 |
| Volume | 1,239,458 |
| Shares Issued | 146.80m |
| Market Cap | $26,035m |
| RiskGrade | 259 |
| Strong Buy | 8 |
| Buy | 6 |
| Neutral | 19 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 34 |

| Time | Volume / Share Price |
| 15:59 | 300 @ $177.38 |
| 15:59 | 200 @ $177.38 |
| 15:59 | 384 @ $177.38 |
| 15:59 | 100 @ $177.34 |
| 15:59 | 100 @ $177.34 |
You are here: research